Request Deal Involvement
Pureos Bioventures and Novo Holdings led a $17m round in Engimmune Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Optimum Strategic Communications
legal advisors
Gorrissen Federspiel
or
Principals
bidder
NOVO HOLDINGS A/S
target
ENGIMMUNE THERAPEUTICS AG
bidder
BASELAUNCH
bidder
PUREOS BIOVENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite